These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 6394811
1. Sixteen adult patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation. Kodera Y, Morishima Y, Morishita Y, Murase T, Okumura M, Yamada H, Minami S, Kato Y, Ogura M, Nagura E. Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():479-85. PubMed ID: 6394811 [Abstract] [Full Text] [Related]
2. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease. Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G. Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095 [Abstract] [Full Text] [Related]
3. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation. Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF. Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249 [Abstract] [Full Text] [Related]
4. Risk factors associated with interstitial pneumonia following allogeneic bone marrow transplantation for acute leukemia in Japanese experience. Inoue T, Masaoka T, Shibata H. Strahlenther Onkol; 1986 Jun; 162(6):368-73. PubMed ID: 3526600 [Abstract] [Full Text] [Related]
5. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis. Martin-Algarra S, Bishop MR, Tarantolo S, Cowles MK, Reed E, Anderson JR, Vose JM, Bierman P, Armitage JO, Kessinger A. Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938 [Abstract] [Full Text] [Related]
6. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission. Inoue T, Ikeda H, Yamazaki H, Tang JT, Song C, Teshima T, Murayama S, Ohtani M, Shibata H, Masaoka T. Strahlenther Onkol; 1993 Apr; 169(4):250-5. PubMed ID: 8488461 [Abstract] [Full Text] [Related]
7. Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT). Corvò R, Lamparelli T, Bruno B, Barra S, Van Lint MT, Vitale V, Bacigalupo A. Bone Marrow Transplant; 2002 Dec; 30(11):717-23. PubMed ID: 12439693 [Abstract] [Full Text] [Related]
8. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation. De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J. Bone Marrow Transplant; 1993 Dec; 12 Suppl 3():S2-6. PubMed ID: 8124252 [Abstract] [Full Text] [Related]
9. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission. Singhal S, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Mehta J. Bone Marrow Transplant; 1996 Apr; 17(4):637-41. PubMed ID: 8722368 [Abstract] [Full Text] [Related]
12. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W. Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [Abstract] [Full Text] [Related]
13. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S. Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323 [Abstract] [Full Text] [Related]
16. [Total body irradiation for bone marrow transplantation in the treatment of leukemia]. Inoue T. Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1538-44. PubMed ID: 3296956 [Abstract] [Full Text] [Related]
18. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation. Glass B, Majolino I, Dreger P, Scimè R, Santoro A, Vasta S, Suttorp M, Haferlach T, Schmitz N. Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054 [Abstract] [Full Text] [Related]
19. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies. Wu DP, Milpied N, Moreau P, Mechinaud-Lacroix F, Mahe B, Le Tortorec S, Rapp MJ, Bourdin S, Mahe JM, Harousseau JL. Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008 [Abstract] [Full Text] [Related]
20. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine. Mehta J, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Middleton G, Eisen T, Singhal S. Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]